High-density lipoprotein function, dysfunction, and reverse cholesterol transport.

Area of Science:

• Cardiovascular Science
• Biochemistry
• Lipid Metabolism

Background:

• Epidemiological studies link high high-density lipoprotein (HDL)-cholesterol to reduced cardiovascular risk.
• Recent genetic and pharmacological data challenge the protective role of HDL.
• Factors like inflammation and myeloperoxidase oxidation can impair HDL function.

Purpose of the Study:

• To investigate the functional aspects of high-density lipoprotein (HDL) beyond cholesterol levels.
• To explore the potential of HDL function tests as cardiovascular risk predictors.

Main Methods:

• Animal models were used to study the effects of raising HDL levels via apolipoprotein A-I infusion or overexpression.
• Evaluated vascular improvements including atherosclerotic lesion progression and regression.
• Assessed the impact of inflammation and oxidative stress on HDL's reverse cholesterol transport, antioxidant, and anti-inflammatory activities.

Main Results:

• Raising HDL levels in animal models demonstrated significant vascular benefits, including delayed atherosclerosis and enhanced reverse cholesterol transport.
• Inflammation and myeloperoxidase-mediated oxidation were identified as detrimental to HDL production and function.
• HDL function was shown to be compromised by these factors, affecting its key activities.

Conclusions:

• HDL's role in cardiovascular health may depend more on its function than its cholesterol level.
• Impaired HDL function due to inflammation and oxidation is a critical concern.
• Functional HDL assays could offer superior cardiovascular risk prediction compared to standard HDL-cholesterol measurements.